Karsten Schmidt
Company: bioJiva
Job title: Chief Technology Officer
Seminars:
Utilizing Docosahexaenoic Acid (DHA) as a possible treatment for Dry AMD 12:00 pm
Exploring the evidence that DHA is oxidized in dry AMD Assessing the capabilities of deuterated DHA to provide protection against oxidative damage in the retina Evaluating available preclinical dataRead more
day: Conference Day 2